Is this study's primary condition wrong?
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
- The registry's first term
- Lymphoma, B-Cell
- ClinicalTrials.gg shows
- Lymphoma, Large B-Cell, Diffuse
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies